Journal of Medical Toxicology

, Volume 3, Issue 3, pp 100–102 | Cite as

The feasibility of administration of activated charcoal with respect to current practice guidelines in emergency department patients

  • Frank LoVecchioEmail author
  • J. Shriki
  • K. Innes
  • J. Bermudez
Toxicology Investigations



The American Academy of Clinical Toxicology, European Association of Poisons Centres, and Clinical Toxicologists recommend administration of activated charcoal (AC) within one-hour of an acute toxic ingestion [1]. Our poison control center periodically and upon request faxes an abbreviated protocol to hospital emergency departments, reminding physicians of these current AC recommendations. This study was conducted to describe how often patients present within the one-hour time frame and how often the guidelines in the above position statement are being followed.


Following a brief training of systematic chart review, reviewers blinded to the purpose of the study completed a standardized data collection sheet. Three years after publication of these consensus statements, a period of 3 consecutive years of poison center patient encounters were reviewed. Recorded data included age, outcomes, and time to administration of charcoal.


Approximately 150,000 reported toxic exposures were reviewed, of which 16,914 patients of acute ingestions presented to a health care facility. The mean age of the group that presented was 25 years [range 1 month-87 years]. A total of 2,700 (16%) patients that presented were within 60 minutes of an acute overdose and all were administered AC in accordance with the recommended guidelines. Interestingly, pre-hospital personnel administered AC within 60 minutes to 762 (28% of 2,700) patients. Correspondingly, 14,214 (84%) patients presented more than 60 minutes after an acute overdose. Of this latter group AC was withheld in 341 (2.4% of 14,214) patients, and 13,873 (97.6% of 14,214) patients received charcoal despite having arrived more than 60 minutes after ingestion. The mean time to the first administration of AC in this latter group was 225 minutes [range of 61–2160 minutes] following ingestion.


Only a small percentage of patients treated for an acute overdose (16%) present within 60 minutes and are given charcoal according to the current guidelines. A large subset of these patients (28%) is given AC in a pre-hospital setting. Few patients presenting to a health care provider after an acute toxic ingestion are treated in accordance with the current recommendations for activated charcoal.


charcoal activated charcoal 


  1. 1.
    Chyka PA, Seger D. Position stataement: single-dose activated charcoal. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists.J Toxicol Clin Toxicol. 1997;35(7):721–741.PubMedCrossRefGoogle Scholar
  2. 2.
    Seger D, Single-dose activated charcoal-backup and reassess.J Toxicol Clin Toxicol. 2004;42(1):101–110.PubMedCrossRefGoogle Scholar
  3. 3.
    Green R, Grierson R, Sitar DS, Tenenbein M. How long after drug ingestion is activated charcoal still effective?J Toxicol Clin Toxicol.2001;39(6):601–605.PubMedCrossRefGoogle Scholar
  4. 4.
    Dawling S, Crome P, Braithwaite R, Effect of delayed administration of activated charcoal on nortirptyline absorption.Eur J Clin pharmacol. Dec 181978;14(6):445–447.PubMedCrossRefGoogle Scholar
  5. 5.
    Laine K, Kivisto KT, Pelttari S, Neuvonen PJ. The effect of activated charcoal on the absorption of fluoextine, with special reference to delayed charcoal administration.Pharmacol Toxicol. Nov1996;79(5):270–273.PubMedCrossRefGoogle Scholar
  6. 6.
    Laine K, Kivisto KT, Ojala-Karlsson P, Neuvonen PJ. Effect of activated charcoal on the pharmacokinetics of pholcodine, with special reference to delayed charcoal ingestion.There Drug Monit. Feb1997;19(1):46–50.CrossRefGoogle Scholar
  7. 7.
    [No authors]Position paper: Ipecac syrup.J Toxicol Clin Toxicol. 2004;42(2):133–43.Google Scholar
  8. 8.
    Isbister GK, Dawson AH, Whyte IM. Feasibility of prehospital treatment with activated charcoal: Who could we treat, who should we treat?Emerg Med J. 2003 Jul;20(4):375–8.PubMedCrossRefGoogle Scholar
  9. 9.
    Thakore S, Murphy N. The potential role of prehospital administration of activated charcoal.Emerg Med J. 2002 Jan;19(1):63–5.PubMedCrossRefGoogle Scholar
  10. 10.
    Bond GR. The role of activated charcoal and gastric emptying in gastrointestinal decontamination: a state-of-the-art review.Ann Emerg Med. 2002 Mar;39(3):273–86.PubMedCrossRefGoogle Scholar
  11. 11.
    Cooper GM, Le Couteur DG, Richardson D, Buckley NA. A randomized clinical trial of activated charcoal for the routine management of oral drug overdose.QJM.2005 Sep;98(9):655–60. Epub2005 Jul 22.PubMedCrossRefGoogle Scholar

Copyright information

© American College of Medical Toxicology 2007

Authors and Affiliations

  • Frank LoVecchio
    • 1
    • 2
    • 3
    Email author
  • J. Shriki
    • 2
    • 3
  • K. Innes
    • 3
  • J. Bermudez
    • 3
  1. 1.Banner Good Samaritan Regional Poison CenterUSA
  2. 2.Maricopa & Banner Good Samaritan Medical CenterUSA
  3. 3.Arizona College of Osteopathic MedicineUSA

Personalised recommendations